BMN 110 (elosulfase alfa)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMN 110 (elosulfase alfa), covering 2014-04-02 to 2014-04-02. Get the full timeline:
Most recent: Clinical Trial Update: BMN 110 US Expanded Access Program